Gravier Pierre
PTC Therapeutics, Inc. · CHIEF FINANCIAL OFFICER
Gravier Pierre is listed in filings as CHIEF FINANCIAL OFFICER at PTC Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 20, 2026, including sale activity. Recent filings connect the profile to PTC Therapeutics, Inc. (PTCT) and Cassava Sciences, Inc. (SAVA). The current snapshot covers public activity from May 27, 2025 to Feb 20, 2026. Reported amounts are shown as $207.5K to $3.8M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| $208k3k shares | SellFeb 18, 2026 | $69.36 | $78.45 |